Psychedelics Research Links September 2021
This is all the other psychedelic research that came out in September 2021.
december 2021
Psychedelics as Medicines Report – Consumer Attitudes Preview
In June 2021, PSYCH and Blossom conducted a nationally representative consumer survey in five countries. The aim of which was to gauge awareness of, and attitudes towards, the potential use of psychedelics for the treatment of a variety of mental health conditions. This section offers a preview of the topline analysis of the survey results.
Research Briefing: Psychedelics for the treatment of addictions
In the Research Briefing of August 27th: 1) The considerable risks of ibogaine 2) Psychiatrists favourable about psychedelics as medicines 3) Quitting tobacco addiction after psychedelic use
Psychedelics Research Links August 2021
This is all the other psychedelic research that came out in August 2021.
Research Briefing: Making psychedelics at scale
In the Research Briefing of July 23rd: 1) LSD increases empathy via oxytocin independent of serotonin receptor activity 2) Low dose LSD engenders therapeutic processes by inducing suggestibility alongside psychosis-like phenomena and mystical experiences 3) Novel gene repression method improves the yield of psilocybin biosynthesis by over 300%
Psychedelics News July 2021
Psychedelic news of July 2021 highlights benefits of psilocybin mushrooms, psychedelics for PTSD, and legalization.
Research Briefing: Will psychedelics change your worldview?
In the Research Briefing of July 8th 1) Sustained improvements in well-being after psychedelic experiences 2) Psychedelic shift metaphysical beliefs away from materialistic 3) Treating anorexia with psychedelics looks promising
Clinical Trials
Psychedelics are set to be approved as medicines after they go through clinical trials | Learn which drugs & companies are taking the lead
Psychedelics Research Links July 2021
This is all the other psychedelic research that came out in July 2021.
Psychedelics Research Recap June 2021
Psychedelic research in June continued the path towards making psychedelics available as medicines. From those who use mental health services to the general public, everyone has to get on board before we can get there.